Éric Fontas

6.7k total citations · 1 hit paper
112 papers, 3.8k citations indexed

About

Éric Fontas is a scholar working on Emergency Medicine, Surgery and Infectious Diseases. According to data from OpenAlex, Éric Fontas has authored 112 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Emergency Medicine, 25 papers in Surgery and 24 papers in Infectious Diseases. Recurrent topics in Éric Fontas's work include HIV-related health complications and treatments (28 papers), HIV/AIDS drug development and treatment (23 papers) and melanin and skin pigmentation (13 papers). Éric Fontas is often cited by papers focused on HIV-related health complications and treatments (28 papers), HIV/AIDS drug development and treatment (23 papers) and melanin and skin pigmentation (13 papers). Éric Fontas collaborates with scholars based in France, United Kingdom and United States. Éric Fontas's co-authors include Peter Reiss, Caroline Sabin, Antonella d’Arminio Monforte, Matthew Law, Thierry Passeron, Andrew Phillips, Wafaa El‐Sadr, Rainer Weber, Jens Lundgren and J.‐P. Lacour and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Éric Fontas

104 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study

2009 481 citations Signe Westring Worm, Caroline Sabin et al. The Journal of Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Éric Fontas France	31	2.0k	1.6k	1.0k	517	509	112	3.8k
Colleen Corcoran United States	23	1.7k 0.9×	1.2k 0.8×	1.4k 1.4×	115 0.2×	318 0.6×	30	3.2k
Cecilia M. Shikuma United States	35	1.8k 0.9×	2.3k 1.4×	2.0k 2.0×	197 0.4×	959 1.9×	156	4.2k
Gregory J. Bagby United States	38	342 0.2×	517 0.3×	387 0.4×	328 0.6×	1.3k 2.5×	124	5.1k
Anita R. Tierney United States	15	1.2k 0.6×	568 0.4×	516 0.5×	560 1.1×	319 0.6×	19	2.4k
Armin Rieger Austria	32	459 0.2×	1.0k 0.6×	643 0.6×	442 0.9×	1.1k 2.2×	123	3.6k
Nicholas Funderburg United States	41	2.6k 1.3×	2.1k 1.3×	2.6k 2.6×	494 1.0×	1.2k 2.4×	132	6.0k
Rudolf Berger Austria	40	143 0.1×	324 0.2×	330 0.3×	686 1.3×	544 1.1×	125	5.4k
Jordi Puig Spain	27	667 0.3×	1.1k 0.7×	910 0.9×	167 0.3×	429 0.8×	102	2.3k
Wei Cao China	18	240 0.1×	1.6k 1.0×	453 0.4×	201 0.4×	401 0.8×	75	2.7k
Maurizio de Martino Italy	29	128 0.1×	406 0.3×	183 0.2×	298 0.6×	719 1.4×	130	3.0k

Countries citing papers authored by Éric Fontas

Since Specialization

Citations

This map shows the geographic impact of Éric Fontas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Fontas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Fontas more than expected).

Fields of papers citing papers by Éric Fontas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éric Fontas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Fontas. The network helps show where Éric Fontas may publish in the future.

Co-authorship network of co-authors of Éric Fontas

This figure shows the co-authorship network connecting the top 25 collaborators of Éric Fontas. A scholar is included among the top collaborators of Éric Fontas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éric Fontas. Éric Fontas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Passeron, Thierry, Éric Fontas, T. Boyé, et al.. (2024). Treatment of Bullous Pemphigoid with Avdoralimab: Multicenter, Randomized, Open-Labeled Phase 2 Study. SHILAP Revista de lepidopterología. 4(6). 100307–100307. 2 indexed citations

Benzaquen, Jonathan, Paul Hofman, Sylvie Leroy, et al.. (2024). Integrating artificial intelligence into lung cancer screening: a randomised controlled trial protocol. BMJ Open. 14(2). e074680–e074680. 4 indexed citations

Chierici, Andréa, et al.. (2024). A Comprehensive Insight into the Economic Profile of People Receiving Metabolic and Bariatric Surgery Use in France. Obesity Surgery. 34(9). 3315–3323.

Chierici, Andréa, et al.. (2024). Bariatric surgery reduces the incidence of hidradenitis suppurativa in individuals with obesity: results of a nationwide administrative data study in France. Surgery for Obesity and Related Diseases. 20(10). 947–952. 2 indexed citations

Arvieux, C., Sandrine Barbois, Éric Fontas, et al.. (2024). SAME day amBulatory Appendectomy (SAMBA): a multicenter, prospective, randomized clinical trial protocol. Trials. 25(1). 601–601.

Joulié, A., et al.. (2024). Intranasal dexmedetomidine for sedation in ABR testing in children: No pain, big gain!. International Journal of Pediatric Otorhinolaryngology. 181. 111981–111981. 1 indexed citations

Chierici, Andréa, Julie Bulsei, Antonio Castaldi, et al.. (2022). Clinical and Economic Impact of Bariatric Surgery Post Liver Transplantation: a Nationwide, Population-Based Retrospective Study. Obesity Surgery. 32(8). 2548–2555. 4 indexed citations

Bulsei, Julie, Andréa Chierici, Marco Alifano, et al.. (2022). Bariatric surgery reduces the risk of pancreatic cancer in individuals with obesity before the age of 50 years: A nationwide administrative data study in France. European Journal of Surgical Oncology. 49(4). 788–793. 9 indexed citations

Iannelli, Antonio, Éric Fontas, David Nocca, et al.. (2022). Four-week omega-3 polyunsaturated fatty acids supplementation for liver left lateral section volume reduction in individuals with morbid obesity undergoing bariatric surgery: A double blind, multicenter, randomized placebo-controlled trial. International Journal of Surgery. 101. 106614–106614. 5 indexed citations

10.

Frachette, Cécile, et al.. (2021). Health‐related quality of life of food‐allergic children compared with healthy controls and other diseases. Pediatric Allergy and Immunology. 33(1). e13663–e13663. 7 indexed citations

11.

Cesaretti, Manuela, Jocelyn Gal, Charles Bouveyron, et al.. (2020). Accurate assessment of nonalcoholic fatty liver disease lesions in liver allograft biopsies by a smartphone platform: A proof of concept. Microscopy Research and Technique. 83(9). 1025–1031. 6 indexed citations

12.

Dunais, Brigitte, P Touboul, Nicolas Degand, et al.. (2015). Impact of the 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage of Streptococcus pneumoniae Among Children Attending Group Daycare in Southeastern France. The Pediatric Infectious Disease Journal. 34(3). 286–288. 20 indexed citations

13.

Sakarovitch, Charlotte, J. Durant, Karine Risso, et al.. (2015). Antiretroviral Regimens and CD4/CD8 Ratio Normalization in HIV-Infected Patients during the Initial Year of Treatment: A Cohort Study. PLoS ONE. 10(10). e0140519–e0140519. 23 indexed citations

14.

Worm, Signe Westring, Mark Bower, Peter Reiss, et al.. (2013). Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: a cohort study. BMC Infectious Diseases. 13(1). 471–471. 58 indexed citations

15.

Petoumenos, Kathy, Signe Westring Worm, Éric Fontas, et al.. (2012). Predicting the short‐term risk of diabetes in HIV‐positive patients: the Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) study. Journal of the International AIDS Society. 15(2). 17426–17426. 53 indexed citations

16.

Fontas, Éric, Isabelle Kousignian, Christian Pradier, et al.. (2010). IL-2 therapy: potential impact of the CD4 cell count at initiation on clinical efficacy--results from the ANRS CO4 cohort. Journal of Antimicrobial Chemotherapy. 65(10). 2215–2223. 4 indexed citations

17.

Friis‐Møller, Nina, Rodolphe Thiébaut, Peter Reiss, et al.. (2010). Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study. European Journal of Cardiovascular Prevention & Rehabilitation. 17(5). 491–501. 283 indexed citations

18.

Fontas, Éric, Isabelle Kousignian, Christian Pradier, et al.. (2009). Interleukine-2 Therapy Does Not Increase the Risk of Hodgkin or Non-Hodgkin Lymphoma in HIV-Infected Patients: Results From FHDH ANRS CO4. JAIDS Journal of Acquired Immune Deficiency Syndromes. 50(2). 206–214. 6 indexed citations

19.

Fontas, Éric, Frank van Leth, Caroline Sabin, et al.. (2004). Lipid Profiles in HIV‐Infected Patients Receiving Combination Antiretroviral Therapy: Are Different Antiretroviral Drugs Associated with Different Lipid Profiles?. The Journal of Infectious Diseases. 189(6). 1056–1074. 274 indexed citations

20.

Mariné–Barjoan, Eugènia, Éric Fontas, Christian Pradier, et al.. (2002). [Registry of liver biopsies from hepatitis C infected patients in the Alpes-Maritimes (France). Results from the first 2 years].. PubMed. 26(1). 57–61. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact